Frederick, MD, United States of America

Raymond Sowder

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Raymond Sowder

Introduction

Raymond Sowder is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of biochemistry, particularly through his work on serine proteases. His innovative approach has led to advancements that are beneficial in various applications.

Latest Patents

Sowder holds a patent for a purified and isolated nucleic acid molecule encoding serine protease, specifically Met-ase. This invention is characterized by its unique activity profile, exhibiting Met-ase activity without Asp-ase activity, and has a molecular weight of about 30,000 daltons on SDS PAGE under both reducing and non-reducing conditions. The patent also includes a vector comprising this nucleic acid molecule and a method for detecting it in a sample.

Career Highlights

Raymond Sowder is associated with the United States of America as represented by the Department of Health. His work has been instrumental in advancing the understanding and application of serine proteases in various scientific fields.

Collaborations

Sowder has collaborated with notable colleagues, including Thomas Sayers and Mark J Smyth. These partnerships have contributed to the success and impact of his research.

Conclusion

Raymond Sowder's contributions to the field of biochemistry through his innovative patent on serine protease highlight his role as a significant inventor. His work continues to influence research and applications in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…